CompletedPhase 1

A Comparative Study on Local Allergic Responses of Bee Venom and Essential Bee Venom Pharmacopuncture

South Korea20 participantsStarted 2015-01

Plain-language summary

This double-blinded randomized clinical trial investigates any differences in allergic responses elicited by Bee Venom (BV) and Essential Bee Venom (eBV).

Who can participate

Age range20 Years – 39 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Individuals with no prior exposure to bee venom treatment * Healthy individuals of both genders, 20 to 39 years old * Individuals able to communicate their thoughts * Voluntary participants who have provided written consent Exclusion Criteria: * Individuals on medications for chronic diseases (i.e. hypertension, hyperlipidemia) * Individuals with past history of allergic dermatitis * Individuals with past history of adverse events following bee stings * Individuals with symptoms of common cold * Individuals with fear of bee venom intervention or those who refuse to participate

What they're measuring

Visual Analog Scale(VAS) on Pain

Timeframe: 0.5 hours after intervention

Wheal and erythema

Timeframe: 24 hours after intervention

Visual Analog Scale(VAS) on Pain

Timeframe: 48 hours after intervention

Trial details

NCT IDNCT02364349

SponsorJaseng Hospital of Korean Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-02

View on ClinicalTrials.gov More Healthy Volunteers trials